A. Smith

发表

The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy

E. Feldman, J. Singleton, B. Bixby, 2008, Journal of the peripheral nervous system : JPNS.

The Diabetic Neuropathies: Practical and Rational Therapy

J. Singleton, A. Smith, 2012, Seminars in Neurology.

Assessing autonomic dysfunction in early diabetic neuropathy

N. Alexander, P. Wren, E. Feldman, 2011, Neurology.

Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy

S. Tripp, J. Singleton, A. Smith, 2001, Neurology.

Weakness (Guillain–Barré Syndrome)

A. Smith, Meng Huan, 2012 .

Assessing the Reproducibility of Quantitative In Vivo Confocal Microscopy of Corneal Nerves in Different Corneal Locations

K. Digre, J. Singleton, A. Smith, 2013, Cornea.

Idiopathic distal sensory polyneuropathy

R. Freeman, R. Dworkin, R. Treister, 2020, Neurology.

Trial designs for chemotherapy-induced peripheral neuropathy prevention

P. Wen, R. Freeman, R. Dworkin, 2018, Neurology.

Clinician-rated measures for distal symmetrical axonal polyneuropathy

R. Freeman, R. Dworkin, L. Burke, 2019, Neurology.

Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation

Lily Wang, E. Feldman, J. Singleton, 2009, Muscle & nerve.

78 – Impaired Glucose Regulation and Neuropathy

J. Singleton, J. Russell, A. Smith, 2007 .

Diagnosis of neuropathy: comment on "tests and expenditures in the initial evaluation of peripheral neuropathy".

A. Smith, 2012, Archives of internal medicine.

A crisis in US drug pricing: Consequences for patients with neuromuscular diseases, physicians and society, part 1

A. Smith, T. Burns, Jason Crowell, 2020, Muscle & nerve.

Increased Blood Pressure Variability Contributes to Worse Outcome After Intracerebral Hemorrhage: An Analysis of ATACH-2

G. Stoddard, N. Rost, D. Tirschwell, 2018, Stroke.

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society

M. Nolano, J. Valls-Solé, S. Mellgren, 2010, Journal of the peripheral nervous system : JPNS.

Three cases of acute myositis in adults following influenza-like illness during the H1N1 pandemic

M. Bromberg, A. Smith, S. Gibson, 2013, Journal of neurosciences in rural practice.

Immune-Mediated Neuropathies.

A. Smith, K. Gwathmey, A. Gordon Smith, 2020, Neurologic clinics.

Reply: 3,4-diaminopyridine in LEMS: Concerns regarding presentation of previous studies

D. Richman, A. Peltier, A. Smith, 2018 .

Idiopathic neuropathy, prediabetes and the metabolic syndrome

J. Singleton, A. Smith, 2006, Journal of the Neurological Sciences.

Pearls and pitfalls in the therapeutic use of botulinum toxin.

A. Smith, 2004, Seminars in neurology.

Relationships between MUNE and muscle strength

A. Smith, V. Lawson, 2003 .

Peripheral Neuropathy Research Registry: A prospective cohort

R. Freeman, S. Ajroud‐Driss, D. Simpson, 2019, Journal of the peripheral nervous system : JPNS.

Peripheral Neuropathy.

A. Smith, Kelsey Barrell, A. Gordon Smith, 2019, The Medical clinics of North America.

Understanding Small Fiber Neuropathy: The Long and Short of It.

J. Kissel, A. Smith, A. Smith, 2016, JAMA neurology.

Diagnostic Yield for Peripheral Neuropathy

M. Bromberg, A. Smith, 2005 .

A rational diagnostic approach to peripheral neuropathy.

M. Bromberg, A. Smith, 2003, Journal of clinical neuromuscular disease.

Normative Values for Electrochemical Skin Conductances and Impact of Ethnicity on Quantitative Assessment of Sudomotor Function.

Barry I. Freedman, Brian C. Callaghan, Aaron I. Vinik, 2016, Diabetes technology & therapeutics.

The diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy.

Sandra P. Reyna, J. Singleton, A. Smith, 2014, Journal of diabetes and its complications.

The hidden costs of painful diabetic neuropathy revealed.

A. Smith, S. Živković, 2020, Neurology. Clinical practice.

"Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy: Cl vs N Phys Trial.

J. Albers, C. Bolton, W. Litchy, 2012, Archives of neurology.

Clinical and pathologic features of focal myositis

A. Smith, W. Grisold, M. Blaivas, 2000, Muscle & nerve.

Treatment of immune-mediated peripheral neuropathy

A. Smith, O. Vardeny, 2005 .

An infant with primary tooth loss and palmar hyperkeratosis: a novel mutation in the NTRK1 gene causing congenital insensitivity to pain with anhidrosis.

J. Carey, K. Swoboda, A. Smith, 2003, Pediatrics.

A crisis in US drug pricing: Consequences for patients with neuromuscular diseases, physicians, and society, part 2

A. Smith, T. Burns, Jason Crowell, 2020, Muscle & nerve.

Clinical and Diagnostic Features of Delayed Hypoxic Leukoencephalopathy

K. Flanigan, A. Smith, T. Schenkenberg, 2008 .

Repetitive use of intra-arterial verapamil in the treatment of reversible cerebral vasoconstriction syndrome

K. Digre, R. Hoesch, A. Smith, 2012, Journal of Clinical Neuroscience.

Do all neuropathy patients need an EMG at least once?

A. Smith, 2014, Continuum.

Assessment of axonal loss in Charcot–Marie–Tooth neuropathies

M. Bromberg, A. Smith, V. Lawson, 2003, Experimental Neurology.

Validation of the triple timed up‐and‐go test in Lambert‐Eaton myasthenia

D. Richman, K. Aleš, A. Smith, 2019, Muscle & nerve.

Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.

R. Conwit, M. Benatar, D. Hafler, 2021, Neurology.

FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm.

R. Holubkov, K. Digre, S. Nandedkar, 2009, Ophthalmology.

Chronic Migraine Is Associated With Reduced Corneal Nerve Fiber Density and Symptoms of Dry Eye

K. C. Brennan, Krista I Kinard, K. Digre, 2015, Headache.

VZV SPINAL CORD INFARCTION IDENTIFIED BY DIFFUSION-WEIGHTED MRI (DWI)

A. Smith, D. Gilden, M. Nagel, 2007, Neurology.

Pulsed electromagnetic fields to reduce diabetic neuropathic pain and stimulate neuronal repair: a randomized controlled trial.

D. Herrmann, A. Smith, S. Cole, 2009, Archives of physical medicine and rehabilitation.

Paraneoplastic myopathy: response to intravenous immunoglobulin

A. Pestronk, K. Flanigan, J. Singleton, 2007, Neuromuscular Disorders.

Lambert–Eaton myasthenic syndrome: Epidemiology and therapeutic response in the national veterans affairs population

A. Smith, J. Greenlee, S. Clardy, 2017, Muscle & nerve.

Updates in diabetic peripheral neuropathy

A. Smith, A. Gordon Smith, Kelsey Juster-Switlyk, 2016, F1000Research.

MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk

A. Smith, T. Kovacsovics, C. Palmer, 2017, Neurology.

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe‐deration of Neurological Societies and the Peripheral Nerve Society

J. Valls-Solé, S. I. Mellgren, O. Johansson, 2010, European journal of neurology.

Toward an efficient method to evaluate peripheral neuropathies.

M. Bromberg, A. Smith, 2002, Journal of clinical neuromuscular disease.

Increased axonal regeneration and swellings in intraepidermal nerve fibers characterize painful phenotypes of diabetic neuropathy.

E. Feldman, J. Singleton, A. Smith, 2013, The journal of pain : official journal of the American Pain Society.

Clinical electrophysiology of axonal polyneuropathies.

A. Smith, D. McCorquodale, Donald Mccorquodale, 2019, Handbook of clinical neurology.

The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy.

J. Singleton, A. Smith, A Gordon Smith, 2004, Archives of internal medicine.

Painful sensory polyneuropathy associated with impaired glucose tolerance

M. Bromberg, J. Singleton, A. Smith, 2001, Muscle & nerve.

Handbook of peripheral neuropathy

M. Bromberg, A. Smith, 2005 .

Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study

C. Schmitz, S. Mellgren, G. Lauria, 2010, Journal of the peripheral nervous system : JPNS.

Diabetic Neuropathy

J. Singleton, A. Smith, 2012, Continuum.

"Correlation Does Not Imply Causation": Bradford Hill, Causative Inference, and Obesity-Related Neuropathy.

A. Smith, 2020, Mayo Clinic proceedings.

Idiopathic neuropathy patients are at high risk for metabolic syndrome

J. Singleton, A. Smith, K. Rose, 2008, Journal of the Neurological Sciences.

Neuropathy associated with prediabetes: What is new in 2007?

A. Smith, J. R. Singleton, 2007, Current diabetes reports.

Glucose intolerance, metabolic syndrome, and neuropathy.

J. Singleton, A. Smith, M. Cortez, 2014, Handbook of clinical neurology.

The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro

A. Windebank, J. Russell, A. Smith, 1994, Neurology.

Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy.

M. Bromberg, A. Smith, J. R. Singleton, 2001, Diabetes care.

NaV channel variants in patients with painful and nonpainful peripheral neuropathy

R. Freeman, S. Ajroud‐Driss, S. Kirov, 2017, Neurology: Genetics.

Neurolymphomatosis of the lumbar plexus: High-resolution MR neurography findings

A. Smith, J. Ward, D. Blumenthal, 2001, Neurology.

The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.

G. Stoddard, J. Singleton, K. Mooney, 2016, JAMA neurology.

Chemotherapy-induced peripheral neuropathy clinical trials

R. Freeman, R. Dworkin, D. Turk, 2017, Neurology.

Microvascular complications of impaired glucose tolerance.

E. Feldman, J. Singleton, J. Russell, 2003, Diabetes.

Polyneuropathy with impaired glucose tolerance: Implications for diagnosis and therapy

E. Feldman, J. Singleton, J. Russell, 2005, Current treatment options in neurology.

Impaired glucose tolerance and metabolic syndrome in idiopathic neuropathy.

A. Smith, 2012, Journal of the peripheral nervous system : JPNS.

Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy

S. Ajroud‐Driss, A. Vinik, B. Cha, 2015, Annals of clinical and translational neurology.

Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy

M. Conaway, J. Russell, A. Smith, 2018, Neurology.

Impaired Glucose Tolerance and Neuropathy

J. Singleton, A. Smith, 2008, The neurologist.

Therapy Insight: neurological complications of prediabetes

J. Singleton, A. Smith, 2006, Nature Clinical Practice Neurology.

Obesity and hyperlipidemia are risk factors for early diabetic neuropathy.

J. Singleton, A. Smith, 2013, Journal of diabetes and its complications.

Microvascular Complications of Impaired Glucose

E. Feldman, J. Russell, A. Smith, 2003 .

Exercise as Therapy for Diabetic and Prediabetic Neuropathy

R. Marcus, J. Singleton, A. Smith, 2015, Current Diabetes Reports.

Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients

R. Marcus, J. Singleton, A. Smith, 2015, Annals of neurology.

Gangliosides for the treatment of diabetic peripheral neuropathy

A. Smith, M. Lunn, C. Kallis, 2017 .

Reevaluating clinical measurement tools in therapeutic trials

A. Smith, T. Burns, 2014, Neurology.

Use of Skin Biopsy in the Diagnosis of Small Fibre Neuropathy

M. Nolano, J. Valls-Solé, C. Sommer, 2010 .

The reliability of skin biopsy with measurement of intraepidermal nerve fiber density

J. McArthur, P. Hauer, J. Singleton, 2005, Journal of the Neurological Sciences.

Clinical Neurophysiology Fellowships-They Can and Should Change.

Pearce J. Korb, A. Smith, 2021, JAMA Neurology.

Content validity of symptom‐based measures for diabetic, chemotherapy, and HIV peripheral neuropathy

R. Freeman, B. Reeve, R. Dworkin, 2017, Muscle & nerve.

Exercise in Type 2 Diabetic Peripheral Neuropathy

R. Marcus, J. Singleton, A. Smith, 2016, Current Geriatrics Reports.

3,4‐diaminopyridine base effectively treats the weakness of Lambert‐Eaton myasthenia

D. Richman, K. Aleš, A. Peltier, 2018, Muscle & nerve.

CISPLATIN NEUROPATHY. AUTHORS' REPLY

E. Hol, A. Windebank, G. Cavaletti, 1995 .

Faculty Opinions recommendation of Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.

A. Smith, Qihua Fan, 2021, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

Dietary management of obesity‐associated neuropathy: Implications for clinical practice and trial design

J. Singleton, A. Smith, 2021, Obesity.

ulsed Electromagnetic Fields to Reduce Diabetic Neuropathic ain and Stimulate Neuronal Repair: A Randomized ontrolled Trial

D. Herrmann, A. Smith, M. Backonja, 2009 .

Hyperglycemia- and neuropathy-induced changes in mitochondria within sensory nerves

E. Feldman, J. Singleton, A. Smith, 2014, Annals of clinical and translational neurology.

Is the Eye a Window to the Peripheral Nerve?

A. Smith, 2023, Neurology.

Electromyography and Neuromuscular Disorders Clinical-Electrophysiologic Correlations

A. Smith, 2006, Neurology.

The Diagnostic Performance and Clinical Relevance of Corneal Confocal Microscopy (CCM) in Patients with Diabetic Peripheral Neuropathy (S44.001)

P. Hauer, J. Singleton, A. Smith, 2016 .

Focal Peripheral Neuropathy

M. Bromberg, A. Smith, 2005 .

Measures of small-fiber neuropathy in HIV infection

D. Haas, T. Hulgan, J. Singleton, 2012, Autonomic Neuroscience.

Exercise for diabetic neuropathy: a toe in the therapeutic door.

R. Marcus, A. Smith, 2012, Journal of diabetes and its complications.

Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.

B. Dobkin, K. Marder, J. Long, 2020, JAMA neurology.

Obesity and hyperlipidemia are risk factors for early diabetic neuropathy.

J. Singleton, A. Smith, 2013, Journal of diabetes and its complications.

Changes in excitability of motor cortical circuitry in primary restless legs syndrome

Christopher R. Jones, J. Petajan, J. Singleton, 1999, Neurology.

Repetitive use of intra-arterial verapamil in the treatment of reversible cerebral vasoconstriction syndrome

K. Digre, R. Hoesch, A. Smith, 2012, Journal of Clinical Neuroscience.

D. Richman, A. Peltier, A. Smith, 2018, Muscle and Nerve.

Peripheral Nerve Histology and Pathology

M. Bromberg, A. Smith, 2005 .